- Home
- LPAA vs ITOS Comparison
LPAA vs ITOS Comparison
Compare LPAA & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPAA
- ITOS
- Stock Information
- Founded
- LPAA 2024
- ITOS 2011
- Country
- LPAA United States
- ITOS United States
- Employees
- LPAA N/A
- ITOS N/A
- Industry
- LPAA
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LPAA
- ITOS Health Care
- Exchange
- LPAA Nasdaq
- ITOS Nasdaq
- Market Cap
- LPAA 286.9M
- ITOS 323.2M
- IPO Year
- LPAA 2024
- ITOS 2020
- Fundamental
- Price
- LPAA $9.98
- ITOS $9.17
- Analyst Decision
- LPAA
- ITOS Strong Buy
- Analyst Count
- LPAA 0
- ITOS 4
- Target Price
- LPAA N/A
- ITOS $32.50
- AVG Volume (30 Days)
- LPAA 22.1K
- ITOS 692.7K
- Earning Date
- LPAA 01-01-0001
- ITOS 11-15-2024
- Dividend Yield
- LPAA N/A
- ITOS N/A
- EPS Growth
- LPAA N/A
- ITOS N/A
- EPS
- LPAA N/A
- ITOS N/A
- Revenue
- LPAA N/A
- ITOS $35,000,000.00
- Revenue This Year
- LPAA N/A
- ITOS $271.18
- Revenue Next Year
- LPAA N/A
- ITOS N/A
- P/E Ratio
- LPAA N/A
- ITOS N/A
- Revenue Growth
- LPAA N/A
- ITOS N/A
- 52 Week Low
- LPAA $9.66
- ITOS $8.41
- 52 Week High
- LPAA $10.03
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- LPAA N/A
- ITOS 42.13
- Support Level
- LPAA N/A
- ITOS $8.41
- Resistance Level
- LPAA N/A
- ITOS $9.64
- Average True Range (ATR)
- LPAA 0.00
- ITOS 0.46
- MACD
- LPAA 0.00
- ITOS 0.20
- Stochastic Oscillator
- LPAA 0.00
- ITOS 54.47
About LPAA Launch One Acquisition Corp. Class A Ordinary shares
Launch One Acquisition Corp is a blank check company.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.